Download PDF
Thromb Haemost 1979; 41(04): 714-717
DOI: 10.1055/s-0038-1646831
Original Articles
Schattauer GmbH Stuttgart

Increase of the Sialic Acid-Rich Variants of the Bβ-and γ-Chains of Fibrinogen Zurich II

P W Straub
The Division of Hematology, Department of Medicine, Kantonsspital, University of Zurich, Switzerland
,
W P Gati
The Division of Hematology, Department of Medicine, Kantonsspital, University of Zurich, Switzerland
› Author Affiliations
Further Information

Publication History

Publication Date:
24 July 2018 (online)

Also available at
  PDF Download  Permissions and Reprints

Summary

The abnormally high sialic acid-content of fibrinogen Zurich II could be attributed to the presence of a higher proportion of the sialic acid-rich L variant of both the γ and Bβ- polypeptide chains of fibrinogen Zurich II as compared to normal fibrinogen.

 

  • References

  • 1 Aminoff D. 1961; Methods for the quantitative estimation of N-acetylneuraminic acid and their application to hydrolysates of sialomucoids. Biochemical Journal 81: 384
    CrossrefPubMedGoogle Scholar
  • 2 Chandrasekhar N, Warren L, Osbahr AJ, Laki K. 1962; Role of sialic acid in fibrinogen. Biochimica et biophysica acta 63: 337
    CrossrefPubMedGoogle Scholar
  • 3 Funk C, Straub PW. 1970; Hereditary abnormality of fibrin monomer aggregation (Fibrinogen Zurich II). European Journal of Clinical Investigation 1: 131
    PubMedGoogle Scholar
  • 4 Gaffney PJ. 1972; Localisation of carbohydrate in the subunits of human fibrinogen and its plasmin induced fragments. Biochimica et biophysica acta 263: 453
    CrossrefPubMedGoogle Scholar
  • 5 Gati WP, Straub PW. 1978; Separation of both the p- and the y-polypeptide chains of human fibrinogen into two main types which differ in sialic acid content. Journal of Biological Chemistry 253: 1315
    PubMedGoogle Scholar
  • 6 Martinez J, Palascak JE, Peters CL. Functional and metabolic studies of human asialofibrinogen. Abstract Vth Congress of the International Society. Thrombosis and Hemostasis. Paris: 21.07.1975: 26
    Google Scholar
  • 7 Mester L, Szabados L. 1968; Differences constitutionnelles dans les fragments glucidiques d’un fibrinogène humain anormal. Comptes Rendus 266: 34
    PubMedGoogle Scholar
  • 8 Mester L, Szabados L. 1970; Structure défectueuse et biosynthése des fractions glucidiques dans les variantes pathologiques du fibrinogéne. Nouvelle Revue FranÇaise d’Hématologie 10: 679
    PubMedGoogle Scholar
  • 9 Mosesson MW, Alkjaersig N, Sweet B, Sherry S. 1967; Human fibrinogen of relatively high solubility. Comparative biophysical, biochemical and biological studies with fibrinogen of lower solubility. Biochemistry 6: 3279
    CrossrefPubMedGoogle Scholar
  • 10 Murano G, Wiman B, Blombäck M, Blombäck B. 1971; Preparation and isolation of the S- carboxymethyl derivative chains of human fibrinogen. FEBS Letters 14: 37
    CrossrefPubMedGoogle Scholar
  • 11 Pepper DS, Gaffney PJ, Blume HD. 1974; The distribution of carbohydrate in the plasmin resistant core fragments (D, E) of human fibrinogen. Biochimica et biophysica acta 365: 203
    CrossrefPubMedGoogle Scholar
  • 12 Pizzo SV, Schwartz ML, Hill RL, Mckee PA. 1972; ITie effect of plasmin on the subunit structure of human fibrinogen. Journal of biological chemistry 247: 636
    PubMedGoogle Scholar
  • 13 Sherman LA, Mosesson MW, Sherry S. 1969; Isolation and characterization of the clottable low molecular weight fibrinogen derived by limited plasmin hydrolysis of human fraction I- 4. Biochemistry 8: 1515
    CrossrefPubMedGoogle Scholar
  • 14 Warren L. 1959; The thiobarbituric acid assay of sialic acids. Journal of biological chemistry 234: 1971
    PubMedGoogle Scholar